{
  "paper_id": "PMC8128869",
  "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128869/",
  "figures": {
    "figure_1": {
      "figure_number": "Figure 1",
      "title": "Figure 1.",
      "caption": "Pathogenesis of disseminated intravascular coagulation. DIC is characterized by systemic activation of blood coagulation, which results in generation and deposition of fibrin, leading to microvascular thrombi contributing to multi-organ dysfunction. Furthermore, consumption of clotting factors and platelets can result in life-threatening hemorrhage.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8364/8128869/602893971d33/41598_2021_89967_Fig1_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8364/8128869/602893971d33/41598_2021_89967_Fig1_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8364/8128869/602893971d33/41598_2021_89967_Fig1_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8364/8128869/602893971d33/41598_2021_89967_Fig1_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig1",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8364/8128869/602893971d33/41598_2021_89967_Fig1_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC8128869/images/figure_1.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8364/8128869/602893971d33/41598_2021_89967_Fig1_HTML.jpg"
    },
    "figure_2": {
      "figure_number": "Figure 2",
      "title": "Figure 2.",
      "caption": "Flowchart depicting literature review and study selection.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8364/8128869/bfff7f1f9aa3/41598_2021_89967_Fig2_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8364/8128869/bfff7f1f9aa3/41598_2021_89967_Fig2_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8364/8128869/bfff7f1f9aa3/41598_2021_89967_Fig2_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8364/8128869/bfff7f1f9aa3/41598_2021_89967_Fig2_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig2",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8364/8128869/bfff7f1f9aa3/41598_2021_89967_Fig2_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC8128869/images/figure_2.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8364/8128869/bfff7f1f9aa3/41598_2021_89967_Fig2_HTML.jpg"
    },
    "figure_3": {
      "figure_number": "Figure 3",
      "title": "Figure 3.",
      "caption": "Forest plots of the standardized mean difference in d-dimer levels. (A) Non severe vs Severe patients. The black squares represent the pooled standardized mean difference effect size for each analysis while the left and right extremes of the squares represent the corresponding 95% confidence intervals for the pooled standardized mean difference effect size for each analysis. All analyses are based on a random-effects model. (B) Survivors vs Non-Survivors. The black squares represent the pooled standardized mean difference effect size for each analysis while the left and right extremes of the squares represent the corresponding 95% confidence intervals for the pooled standardized mean difference effect size for each analysis. All analyses are based on a random-effects model.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8364/8128869/a555497526aa/41598_2021_89967_Fig3_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8364/8128869/a555497526aa/41598_2021_89967_Fig3_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8364/8128869/a555497526aa/41598_2021_89967_Fig3_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8364/8128869/a555497526aa/41598_2021_89967_Fig3_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig3",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8364/8128869/a555497526aa/41598_2021_89967_Fig3_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC8128869/images/figure_3.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8364/8128869/a555497526aa/41598_2021_89967_Fig3_HTML.jpg"
    },
    "figure_4": {
      "figure_number": "Figure 4",
      "title": "Figure 4.",
      "caption": "Forest plots of the standardized mean difference in platelets count (PLT), prothrombin time (PT) and activated partial thromboplastin time (aPTT). (A–C) Forest plots of the standard mean difference in PLT count, PT and aPTT between Non Severe and Severe patients. (D–F) Forest plots of the standard mean difference in PLT count, PT and aPTT between Survivors and Non-Survivors.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8364/8128869/d059cdae5cc3/41598_2021_89967_Fig4_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8364/8128869/d059cdae5cc3/41598_2021_89967_Fig4_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8364/8128869/d059cdae5cc3/41598_2021_89967_Fig4_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8364/8128869/d059cdae5cc3/41598_2021_89967_Fig4_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig4",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8364/8128869/d059cdae5cc3/41598_2021_89967_Fig4_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC8128869/images/figure_4.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8364/8128869/d059cdae5cc3/41598_2021_89967_Fig4_HTML.jpg"
    }
  },
  "claims": [
    {
      "sentence": "Similarly, several patients with severe COVID-19 infection can develop a coagulopathy according to the International Society on Thrombosis and Haemostasis (ISTH) criteria for disseminated intravascular coagulopathy (DIC) with fulminant activation of coagulation4, resulting in widespread microvascular thrombosis and consumption of coagulation factors (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Similarly, several patients with severe COVID-19 infection can develop a coagulopathy according to the International Society on Thrombosis and Haemostasis (ISTH) criteria for disseminated intravascular coagulopathy (DIC) with fulminant activation of coagulation4, resulting in widespread microvascular thrombosis and consumption of coagulation factors (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "The study selection procedure is reported in detail in Fig. 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The study selection procedure is reported in detail in Fig. 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The primary analysis showed that mean d-dimer is significantly lower in COVID-19 patients with non-severe disease than in those with severe infection (SMD − 2.15 [− 2.73 to − 1.56], I2 98%, P < 0.0001) (Fig. 3, panel A).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Similarly, we found a much lower mean d-dimer in Survivors compared to Non-Survivors (SMD − 2.91 [− 3.87 to − 1.96], I2 98%, P < 0.0001) (Fig. 3, panel B).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Additional analysis of platelet count showed higher mean PLT in Non-Severe patients than those observed in the Severe group (SMD 0.77 [0.32 to 1.22], I2 96%, P < 0.001) (Fig. 4, panel A).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Of note, a similar result was observed even when Survivors were compared to Non-Survivors (SMD 1.84 [1.16 to 2.53], I2 97%, P < 0.0001) (Fig. 4, panel D).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Interestingly, shorter mean PT was found in both Non-Severe (SMD − 1.34 [− 2.06 to − 0.62], I2 98%, P < 0.0002) (Fig. 4, panel B) and Survivors groups (SMD − 1.61 [− 2.69 to − 0.54], I2 98%, P < 0.003) (Fig. 4, panel E) compared to Severe and Non-Survivor patients.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    }
  ],
  "extraction_stats": {
    "figures_count": 4,
    "claims_count": 9,
    "images_downloaded": 4,
    "tables_filtered": 217
  }
}